VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIBODIES MARKET ANALYSIS

Vascular Endothelial Growth Factor Antibodies Market, By Drug (Avastin, Cometriq, Eylea, Jetrea, Cyramza, Macugen, Lucentis, and Others), By Route of Administration (Oral, Intravenous, and Intravitreal), By Application (Cancer, Ophthalmology, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1614
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Key players operating in the vascular endothelial growth factor (VEGF) antibodies market include Genentech, Inc., Novartis, Exelixis, Inc., Eli Lilly and Company, Bayer Pharma AG, Regeneron Pharmaceuticals, Inc., Valeant Pharmaceuticals, Ceres Oncology Pty Ltd, and ThromboGenics, Inc.